Continuous glucose monitoring for better diabetes control
Part of Hormones & metabolism clinical trials.
This study will look at how well Dexcom continuous glucose monitors (CGMs) work in real life. It helps people with diabetes track their blood sugar levels and may lead to better control of their condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be prescribed or eligible to use a Dexcom continuous glucose monitor.
- You need a recent blood test (HbA1c) from the last 3 months.
- You are willing to use the Dexcom device as directed and complete surveys.
- You will have at least one follow-up visit with your doctor after starting the device.
- You are not in another study where you are getting an experimental treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using a continuous glucose monitor (a small sensor that tracks blood sugar all day) in people with type 2 diabetes who are not taking insulin. It aims to see if using the monitor helps improve blood sugar control.
This study tests whether using a small sensor (continuous glucose monitor) to check your blood sugar while you're in the hospital can improve diabetes management. You'll wear the sensor for a few days and may not need as many finger-prick tests.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This study tests a continuous glucose monitor (a small sensor that tracks your blood sugar) for 20 days. It's for people with prediabetes to see how their blood sugar changes throughout the day and potentially help manage their condition.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.